A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| 1. autor: | |
|---|---|
| Kolejni autorzy: | |
| Format: | Praca dyplomowa |
| Język: | English |
| Wydane: |
Brac University
2024
|
| Hasła przedmiotowe: | |
| Dostęp online: | http://hdl.handle.net/10361/24298 |